Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on nerve & pain health. Browse all Nerve & Pain Health education

Burning Mouth Syndrome (BMS) is a chronic condition marked by a persistent burning sensation in the mouth — often on the tongue, lips, or palate — with no obvious sore or lesion to explain it. It can be baffling and distressing, and its causes are still not fully understood. Genetics appears to be part of the story, particularly the genes that govern how nerves sense and process pain.

This article explains what BMS is, the genetic factors researchers are studying, and evidence-based approaches to management — always in partnership with a qualified provider.

What Burning Mouth Syndrome is

Clinicians divide BMS into two types. Primary (idiopathic) BMS has no identifiable underlying cause and is considered a neuropathic pain disorder — a problem with how nerves signal, rather than damage you can see. Secondary BMS results from an identifiable factor such as a nutritional deficiency, dry mouth, oral infection, acid reflux, hormonal change, or medication side effect. Because the two forms are managed very differently, sorting out which one is present is the first clinical step.

The genetics of pain perception

Primary BMS is understood as a neuropathic condition, so the genes that shape pain sensitivity are especially relevant. COMT (notably the rs4680 variant) controls how quickly the body breaks down catecholamines and is one of the most studied genes in chronic pain — variants are associated with differences in pain sensitivity and how the nervous system amplifies discomfort. TRPV1, the receptor that responds to capsaicin and heat, is directly involved in the burning quality of oral pain. SCN9A, which encodes a sodium channel central to pain signaling, is another candidate in neuropathic pain research. Together these genes help explain why identical stimuli feel very different from one person to the next.

Nutritional and metabolic links

Secondary BMS is frequently connected to deficiencies in B vitamins, folate, iron, or zinc. Here, genes involved in nutrient metabolism become relevant. MTHFR, which affects folate and B-vitamin processing, is a well-known example — impaired methylation can contribute to the nutritional shortfalls sometimes found in BMS. Identifying and correcting an underlying deficiency, when one exists, is a core part of addressing secondary BMS.

Other contributing factors

BMS rarely has a single cause. Hormonal shifts — it is more common in peri- and post-menopausal women — dry mouth, anxiety and depression, teeth grinding, allergic reactions to dental materials, and certain medications can all contribute. This multifactorial nature is exactly why a careful, individualized evaluation matters more than any one-size-fits-all explanation.

Approaches to management

Management is directed by a clinician, typically a physician or dentist familiar with orofacial pain, and is tailored to whether BMS is primary or secondary. General, evidence-based strategies include correcting any confirmed nutritional deficiency, addressing dry mouth and staying well hydrated, identifying and avoiding personal triggers such as acidic or spicy foods, managing stress and anxiety, and reviewing medications with a provider. For neuropathic primary BMS, clinicians may consider specific therapies — decisions that belong with your care team, not a self-directed protocol.

What genetic insight adds

Genetic testing cannot diagnose Burning Mouth Syndrome, which remains a clinical diagnosis of exclusion. It can add context about how your body is wired for pain and nutrient metabolism. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across peptide-related biological pathways — including nerve-signaling and metabolic biology where genes like COMT, TRPV1, and MTHFR operate. Results give you and your provider one more informed input. Genetics is a guide, not a guarantee. Related reading: the genetic basis and management of neuropathic pain.

Frequently Asked Questions

Is Burning Mouth Syndrome genetic?

Partly. There is no single "BMS gene," but variants in pain-processing genes such as COMT, TRPV1, and SCN9A influence how intensely nerves signal discomfort, and nutrient-metabolism genes like MTHFR can play a role in secondary BMS. Genetics is one contributor among several interacting factors.

Can genetic testing diagnose BMS?

No. Burning Mouth Syndrome is a clinical diagnosis of exclusion, made by a physician or dentist after ruling out other causes such as deficiencies, dry mouth, or infection. Genetic testing offers pathway-level context about pain and nutrient biology, not a diagnosis of the condition itself.

Do B vitamins help Burning Mouth Syndrome?

They may help when BMS is secondary to a confirmed deficiency in B vitamins, folate, iron, or zinc. Correcting a documented shortfall can ease symptoms in those cases. Supplementing without a confirmed deficiency is unlikely to help, so testing and provider guidance come first.

Does COMT affect pain?

Yes. COMT breaks down catecholamines like dopamine and norepinephrine, and its rs4680 variant is one of the most studied genetic influences on pain sensitivity. Certain versions are associated with heightened pain perception, which is why COMT appears frequently in research on neuropathic and chronic pain conditions.

Curious how your pain and nutrient pathways are wired? Take the Precision Peptide Genetic Test.

This article is part of the PlexusDx Education Hub. Browse all Nerve & Pain Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.